Literature DB >> 8500872

Immunocompromise in gnotobiotic pigs induced by verotoxin-producing Escherichia coli (O111:NM).

J Christopher-Hennings1, J A Willgohs, D H Francis, U A Raman, R A Moxley, D J Hurley.   

Abstract

A verotoxin-producing Escherichia coli serotype O111:NM strain (strain 10049; verotoxin 1 positive) persistently infected experimentally inoculated gnotobiotic pigs, causing attaching-effecting intestinal lesions and chronic diarrhea. Experiments were performed to determine whether persistent infection might be associated with immunocompromise of the host of this organism. Pigs inoculated with this strain had a significant reduction in peripheral blood lymphocytes and lower antibody titers to sheep erythrocytes compared with control pigs. Compared with pigs given a verotoxin-negative pathogenic strain of the same serotype (O111:NM, strain 2430), pigs inoculated with the verotoxin-positive strain had lower peripheral lymphocyte counts and proliferative responses to concanavalin A, phytohemagglutinin, and pokeweed mitogens. The results of this study suggest that strain 10049 has an immunocompromising effect on gnotobiotic pigs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500872      PMCID: PMC280849          DOI: 10.1128/iai.61.6.2304-2308.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis.

Authors:  D H Francis; J E Collins; J R Duimstra
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

2.  The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets.

Authors:  S Tzipori; I K Wachsmuth; C Chapman; R Birden; J Brittingham; C Jackson; J Hogg
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

3.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

Review 4.  Hemolytic-uremic syndrome. Current concepts and management.

Authors:  J S Fong; J P de Chadarevian; B S Kaplan
Journal:  Pediatr Clin North Am       Date:  1982-08       Impact factor: 3.278

Review 5.  Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis.

Authors:  M M Levine; R Edelman
Journal:  Epidemiol Rev       Date:  1984       Impact factor: 6.222

6.  Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP).

Authors:  D M Morrison; D L Tyrrell; L D Jewell
Journal:  Am J Clin Pathol       Date:  1986-07       Impact factor: 2.493

7.  Quantitative microtiter cytotoxicity assay for Shigella toxin.

Authors:  M K Gentry; J M Dalrymple
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

8.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

9.  Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli.

Authors:  C R Clausen; D L Christie
Journal:  J Pediatr       Date:  1982-03       Impact factor: 4.406

10.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck; M R Thompson; S B Formal
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

View more
  8 in total

1.  Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro.

Authors:  C Menge; L H Wieler; T Schlapp; G Baljer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.

Authors:  Mark A Hoffman; Christian Menge; Thomas A Casey; William Laegreid; Brad T Bosworth; Evelyn A Dean-Nystrom
Journal:  Clin Vaccine Immunol       Date:  2006-10-18

3.  Gene conservation and loss in the mutS-rpoS genomic region of pathogenic Escherichia coli.

Authors:  C J Herbelin; S C Chirillo; K A Melnick; T S Whittam
Journal:  J Bacteriol       Date:  2000-10       Impact factor: 3.490

4.  Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.

Authors:  Kellie R K Winter; William C Stoffregen; Evelyn A Dean-Nystrom
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

5.  Escherichia coli serogroup O111 includes several clones of diarrheagenic strains with different virulence properties.

Authors:  L C Campos; T S Whittam; T A Gomes; J R Andrade; L R Trabulsi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1.

Authors:  M A Karmali; M Petric; M Winkler; M Bielaszewska; J Brunton; N van de Kar; T Morooka; G B Nair; S E Richardson; G S Arbus
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

Review 7.  The piglet as a model for B cell and immune system development.

Authors:  J E Butler; K M Lager; I Splichal; D Francis; I Kacskovics; M Sinkora; N Wertz; J Sun; Y Zhao; W R Brown; R DeWald; S Dierks; S Muyldermans; J K Lunney; P B McCray; C S Rogers; M J Welsh; P Navarro; F Klobasa; F Habe; J Ramsoondar
Journal:  Vet Immunol Immunopathol       Date:  2008-11-01       Impact factor: 2.046

Review 8.  The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle.

Authors:  Christian Menge
Journal:  Toxins (Basel)       Date:  2020-09-21       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.